iifl-logo

Biocon Ltd Historical Data

311.85
(-4.56%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Biocon Ltd Historical Data

25/03/2025calendar-icon
25/04/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

26-Mar-2025

348

352.6345.8348.317,01949,92,50,332.856,29,416

27-Mar-2025

348.5

350.25342.5345.5519,72747,25,31,250.24,64,184

28-Mar-2025

344.95

349.3339.35341.729,77180,05,05,997.159,11,518

01-Apr-2025

338.5

348.55338.2339.120,65436,64,60,096.83,07,115

02-Apr-2025

337.85

344.5334.85342.0517,57431,85,92,506.22,46,389

03-Apr-2025

349

357.4344.2345.7535,8751,24,99,73,087.958,10,635

04-Apr-2025

342.55

343.2321.3327.839,1521,22,33,38,321.6514,44,109

07-Apr-2025

299.1

311.75299307.549,05681,10,92,236.857,02,897

08-Apr-2025

312.05

327.4308.5322.350,0451,30,78,01,956.89,40,278

09-Apr-2025

315.65

316.1305306.339,3301,07,45,90,956.959,57,883

11-Apr-2025

320

323313.6316.5528,28397,01,51,420.76,51,014

15-Apr-2025

321

330.65319.7328.8531,7761,05,18,40,257.9515,99,476

16-Apr-2025

329.05

331.7327.45329.1525,62041,20,27,883.554,22,995

17-Apr-2025

329.1

333327.55331.311,54331,75,52,946.852,61,123

21-Apr-2025

335.8

335.8329.2331.945,39861,85,88,949.68,29,958

22-Apr-2025

332.45

337.25327.7333.836,58078,48,72,518.758,80,837

23-Apr-2025

336.15

339.5333.1335.732,65890,32,83,985.8512,07,469

24-Apr-2025

334

335325.05326.7543,4631,54,64,74,413.214,43,613

Biocon: Related NEWS

Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan
24 Apr 2025|09:50 PM

The fundraising may be executed in one or more tranches using QIP, rights issues, or any other permissible route under regulatory guidelines.

Read More
Top Stocks for Today - 24th April 2025
24 Apr 2025|06:20 AM

Here are some of the stocks that may see significant price movement today: LTIMindtree, Dalmia Bharat, Bajaj Housing, etc.

Read More
Biocon unit expands oncology portfolio after USFDA approval
11 Apr 2025|09:00 AM

Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its receptors.

Read More
Biocon Pharma Gains USFDA Approval for Norepinephrine and Key Therapies
24 Mar 2025|11:51 PM

The first approval is for the 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths of Lenalidomide Capsules.

Read More
Biocon Biologics inks pact with Civica to expand access in US
7 Mar 2025|08:53 AM

Civica will start selling the medicine for patients in the United States after completing development work and clinical trials.

Read More
Biocon Secures USFDA Approval for Dasatinib
5 Mar 2025|01:40 PM

The drug is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) in adults who have shown resistance or intolerance to prior therapy.

Read More
Biocon launches generic Liraglutide in the UK
28 Feb 2025|01:53 PM

Biocon will market Liraglutide under two brand names - Liraglutide Biocon for diabetes, which is a generic version of Victoza.

Read More
Biocon Biologics introduces stelara biosimilar YESINTEK in US
25 Feb 2025|09:00 AM

As per the company, YESINTEK shall be available in all the same formulations currently provided by Stelara.

Read More
Top Stocks for Today - 25th February 2025
25 Feb 2025|07:03 AM

Here are some of the stocks that may see significant price movement today: Biocon, NTPC Green Energy, LIC, etc.

Read More
Biocon Q3 Revenue Up 10%, EBITDA Rises 16%
31 Jan 2025|11:07 AM

Biocon's EBITDA increased by 16% YoY to ₹787 crore, which shows improved operational performance.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.